| Dr Rebecca Rae Ulep, DO | |
|
159 Executive Dr Ste F, Danville, VA 24541-4160 | |
| (434) 792-4378 | |
| Not Available |
| Full Name | Dr Rebecca Rae Ulep |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 159 Executive Dr Ste F, Danville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114186426 | NPI | - | NPPES |
| 1114186426 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0102203922 (Virginia) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0102203922 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Healthcare Manistee Hospital | Manistee, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sound Inpatient Physicians-michigan Pllc | 5395896849 | 213 |
News Archive
A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.
People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.
Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.
People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.
Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013180181 PECOS PAC ID: 4486703170 Enrollment ID: O20090529000290 |
News Archive
A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.
People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.
Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
› Verified 1 days ago
| Entity Name | Sound Inpatient Physicians-michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639311996 PECOS PAC ID: 5395896849 Enrollment ID: O20090624000252 |
News Archive
A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.
People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.
Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca Rae Ulep, DO 159 Executive Dr Ste F, Danville, VA 24541-4160 Ph: (434) 792-4378 | Dr Rebecca Rae Ulep, DO 159 Executive Dr Ste F, Danville, VA 24541-4160 Ph: (434) 792-4378 |
News Archive
A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.
People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.
Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
› Verified 1 days ago
Dr. Buddy Buford Stokes Ii, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1955 Memorial Dr, Danville, VA 24541 Phone: 434-799-2055 Fax: 434-799-2044 | |
Dr. Daniel Demetrios Collector, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 109 Bridge St Ste 201, Danville, VA 24541 Phone: 434-799-4488 Fax: 434-773-6977 | |
Dr. Timothy Wayne Brotherton, M,D, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Ste J, Danville, VA 24541 Phone: 434-793-0044 Fax: 434-792-8864 | |
Syed Aftab Ahmed, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Suite K, Danville, VA 24541 Phone: 434-792-7471 Fax: 434-792-1087 | |
Dr. Stecker Tam Pierson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr Ste H, Danville, VA 24541 Phone: 434-791-1345 Fax: 434-773-6811 | |
Subash Ala, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-2225 | |
Sheranda C Gunn-nolan, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-3859 Fax: 434-773-6803 |